MEET THE CANCER SCIENTISTS ON OUR MEDICAL RESEARCH ADVISORY COMMITTEE

OUR MEDICAL RESEARCH ADVISORY COMMITTEE

• 

  PROFESSOR MICHELLE HABER AM, BSC (PSYCH) (HONS), PHD, HON DSC (UNSW), FAHMS

  Co-Chair of the ACRF Medical Research Advisory Committee

  Appointed to the MRAC in 2012. Executive Director, Children’s Cancer Institute Australia, Sydney; Head of Program, Experimental Therapeutics; Conjoint Professor, Faculty of Medicine, University of NSW.

• 

  PROFESSOR RICKY JOHNSTONE PhD

  Co-Chair of the ACRF Medical Research Advisory Committee

  Appointed to the MRAC in 2019 Executive Director Cancer Research, Peter MacCallum Cancer Centre; Professorial Fellow (Professor), The Sir Peter MacCallum Department of Oncology, University of Melbourne; Associate Director of Laboratory Research, Peter MacCallum Cancer Centre; NHMRC Senior Principal Research Fellowship. The Peter MacCallum Cancer Centre; Senior Fellow in the Department of Biochemistry, University of Melbourne; Assistant Director of Research, Peter MacCallum Cancer Centre; Co-Head, Cancer Therapeutics Program, Peter MacCallum Cancer Centre

• 

  PROFESSOR ROGER REDDEL AO, BSC (MED), MBBS, PhD, FRACP, FAA

  Appointed to the MRAC in 2012. Director of Children’s Medical Research Institute (CMRI), Westmead Sydney; Sir Lorimer Dods Professor, Sydney University; Head of CMRI’s Cancer Research Unit, Director Cellbank of Australia and Co-Director of ProCan®.

• 

  PROFESSOR MICHAEL BROWN MBBS, FRACP, FRCPA

  Appointed to the MRAC in 2016. Director, Cancer Clinical Trials Unit, and Senior Consultant, Department of Medical Oncology, Royal Adelaide Hospital Cancer Centre; Clinical Professor, School of Medicine, The University of Adelaide; Affiliate Professor, School of Biological Sciences, The University of Adelaide; Adjunct Professor, School of Pharmacy and Medical Sciences, University of South Australia; Head, Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology, Adelaide.

• 

  Professor.Dr Sjoerd Van Der Burg PhD
  

  Appointed to the MRAC in 2017. Advisor for the immunomonitoring of spontaneous and immune therapy induced immune responses at the Dutch Cancer Institute, Amsterdam, The Netherlands. Full professor in the immunotherapy of solid tumours at the University of Leiden. Head of the laboratory of Experimental Oncology of the departments of Clinical Oncology and Ophthalmology, Leiden University Medical Center, The Netherlands.

• 

  PROFESSOR DAVID CAMERON
  BA (HONS), DES, MA, MBBS, MRCP (UK), MSC, CCST, MD, FRCP EDIN.

  Appointed to the MRAC in 2017. Professor of Oncology & Director of Cancer Services NHS Lothian, Edinburgh Cancer Research Centre, The University of Edinburgh.

• 

  PROFESSOR GEOFF HILL MBCHB, MD, FRACP, FRCPA

  Appointed to the MRAC in 2008 NHRMC Aust Fellow. Full Member José Carreras / E. Donnall Thomas Endowed Chair for Cancer Research; Clinical Research Division, Fred Hutchinson Cancer Research Center; Director of Hematopoietic Stem Cell Transplantation, Seattle Cancer Care Alliance; Professor of Medicine, Division of Medical Oncology, University of Washington

• 

  PROFESSOR PAUL LAMBERT BS, PHD, POSTDOC

  Appointed to the MRAC in 2014. Howard M Termin Professor of Oncology at the University of Wisconsin; Editorial Board Member of the Journal of Virology; Director, University of Wisconsin Cancer Biology Graduate Program, and Virology Training Program.

• 

  PROFESSOR ANGEL LOPEZ MBBS, PHD, FRCPA, FAA

  Appointed to the MRAC in 2014 Co-Director of the Centre for Cancer Biology; Head of Division of Human Immunology, Centre for Cancer Biology, Adelaide.

• 

  PROFESSOR JENNIFER STOW, BSC (HONS), PHD

  Appointed to the MRAC in 2009. NHMRC Principal Research Fellow; Deputy Director (Research) and Group Leader, Cell Biology and Molecular Medicine Division, Centre for Inflammation and Disease Research, Institute for Molecular Bioscience, University of Queensland.

• 

  PROFESSOR CONNIE TRIMBLE, MD

  Appointed to the MRAC in 2014. Associate Professor of Gynecology, Obstetrics and Oncology, John Hopkins School of Medicine, Baltimore, USA. Diplomat of the American Board of Pathology and the American Board of Obstetrics and Gynecology; Fellow of the American Congress of Obstetricians and Gynecologists.

• 

  PROFESSOR MATHEW A VADAS AO, FAHMS, BSC, MB, BS, PHD, DSC

  Executive Director, Centenary Institute of Cancer Medicine & Cell Biology; Professor of Medicine, University of Sydney, Central Clinical School.

• 

  PROFESSOR HELEN RIZOS BSc (Hons1), PhD

  Appointed to the MRAC in 2019 NHMRC Senior Research Fellow; Head of Department, Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University.

• 

  PROFESSOR CLARE SCOTT MB AM BS PhD Melbourne FRACP

  Appointed to the MRAC in 2019 Joint Division Head, Clinical Translation (Cancer), Walter & Eliza Hall Institute; Chair, Gynaecological Cancer, Faculty of Medicine, University of Melbourne; Laboratory Head, Victorian Cancer Agency Clinical Fellow, Cancer Biology and Stem Cells Division, Walter & Eliza Hall Institute.

• 

  PROFESSOR PETER LEEDMAN AO, MBBS, PhD, FRACP, FAHMS

  Appointed to the MRAC in 2019 Director, Harry Perkins Institute of Medical Research, WA; Professor of Medicine, University of WA.

• 

  DR NIC WADDELL BSC, PHD

  Appointed to the MRAC in 2022. Head of the Medical Genomics group and coordinator of the Cancer Program at QIMR Berghofer Medical Research Institute in Brisbane, Queensland; Member, Executive Committee for Australian Genomic Technologies Association; Member, Australian Genomics; Research Committee Member, Cure Cancer Australia; Member, Queensland Genomics Community Advisory Group; Co-founder and Board Member, genomiQa; Cancer Institute NSW Research Committee; Associate Member, Australian Academy of Health and Medical Sciences Mentoring Scheme

• 

  PROFESSOR IAN FRAZER AC, FRS, FAA, MB, CHB (EDINBURGH), MD (MELBOURNE)

  On sabbatical

  Appointed to the MRAC in 2005, Chairman 2009-2017. Professor, School of Medicine, The University of Queensland; Head, Cancer Immunology Program, UQDI; Board Chair, TRI Foundation; Chair, Advisory Board, Medical Research Future Fund.